IFF Pharma Solutions Archives

27 May 2024

IFF to unveil alginate technology for biomedical innovation

By Staff Writer

A global leader in food and beverage, home and personal care and health, IFF will unveil groundbreaking study results at upcoming major biomedical conferences. These results highlight how IFF Pharma Solutions NovaMatrix® portfolio of ultrapure alginate biopolymers could revolutionise regenerative medicine and 3D cell culture applications. At the 12th World Biomaterials Congress (WBC), IFF Pharma Solutions will showcase a...

03 Oct 2023

IFF launches novel excipient formulations

By Staff Writer

IFF’s Pharma Solutions division brings the power of leading excipient products for the pharmaceutical industry to CPHI 2023 in Barcelona, Spain from 24 to 26 October. The team will provide visitors with a first-hand preview of new products, investments and innovations. They will also spotlight the company’s strategic initiatives in sustainability, quality, and reliability for pharmaceutical customers. Low nitrite...

01 Nov 2022

IFF showcases excipient expertise at CPhI Frankfurt

By Staff Writer

IFF’s Pharma Solutions is showcasing best-in-class cellulosic excipient expertise, including leading brands like Avicel® and METHOCEL™ at CPhI. IFF’s Pharma Solutions division is backed by 300 years of combined cellulosic excipient experience. It is home to leading brands like Avicel® and METHOCEL™ and developed a robust seaweed-based excipient portfolio. The division is at CPhI Frankfurt this week to showcase its technical...

11 Nov 2021

IFF showcases cellulosic excipients at CPhI

By Staff Writer

IFF’s Pharma Solutions will reaffirm its commitment to helping customers globally deliver consistent, high-quality products at this year’s CPhI Worldwide and CPhI China. The company is backed by 300 years of combined cellulosic excipient experience, including leading brands like Avicel and METHOCEL, a robust seaweed-based excipient portfolio and deep technical expertise. Highly customised excipient solutions...